Sanfilippo,GC Pharma,Regulatory,Treatment,Regulatory

Breakthrough in Genetic Disorder Treatment: GC Pharma’s Sanfilippo Syndrome Drug Receives FDA Phase 1 Approval

Sanfilippo Syndrome, also known as Mucopolysaccharidosis Type III, is a rare genetic disorder caused by the body’s inability to produce…
Alzheimer,Electromagnetic,Therapy,Treatment,Market

Revolutionizing Alzheimer’s Treatment: The Dawn of Electromagnetic Drug-Free Therapy

Understanding the Technology Electromagnetic therapy utilizes magnetic fields to stimulate specific areas of the brain, a technique that has shown…
Cancer,Therapy,ADC,Mechanism,Treatment

Revolutionary Cancer Treatment: ADC’s Triumph in Medical Science

The Battle Against Cancer: An Unfinished Quest Despite advancements across millennia, cancer remains a formidable challenge, eluding definitive conquest. Historical…

Diabetes: The Sweet Devil Threatening Korea

Astonishing Prevalence: Korea has one of the highest diabetes prevalence rates among OECD countries. In 2020, 13.8% of the adult…

Cardiovascular Disease: A Threat Looming Over the Health of Koreans

Cardiovascular disease encompasses a range of conditions affecting the heart and blood vessels. It manifests in various forms, including heart…

Cancer: The Leading Cause of Death for Koreans: A Comprehensive Guide to Prevention, Detection, and Treatment

The most common cancers in Korea are lung cancer, colorectal cancer, stomach cancer, liver cancer, and breast cancer. These cancers…